By Josh White
Date: Monday 04 Sep 2023
(Sharecast News) - UK-based biotechnology company ReNeuron Group, which specialises in stem cell-derived exosome technologies, announced significant advancements in the field of exosome research on Monday.
By Iain Gilbert
Date: Tuesday 24 Jan 2023
(Sharecast News) - Reneuron revealed on Tuesday that chief financial officer John Hawkins had acquired 100,000 ordinary shares in the AIM-listed stem cell technologies group.
By Josh White
Date: Friday 02 Dec 2022
(Sharecast News) - Stem-cell-derived exosome technology specialist ReNeuron Group reported first-half revenue of £0.44m on Friday, up from £0.06m year-on-year, related to income from partner-funded development activities and royalty income.
Currency | UK Pounds |
Share Price | 3.38p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 11.13 |
52 Week Low | 3.38 |
Volume | 0 |
Shares Issued | 57.17m |
Market Cap | £1.93m |
RiskGrade | 394 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 1 |
Buy | 0 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 1 |
No dividends found |
You are here: research